Table 1.
Socio-Demographic data, disease outcomes, treatment, and mental health sample characteristics
| Variables | Means±SD or n (%) |
| Sociodemographic | |
| Age, years | 43.4±12.6 |
| Sex, male | 777 (35.9%) |
| Having a partner (n=2,165) | 1,716 (79.3%) |
| Education level, university studies | 1,119 (51.7%) |
| Job status, employee (n=2,051) | 1,132 (52.3%) |
| Patient organisation membership | 806 (37.2%) |
| Disease outcomes | |
| BASDAI (0–10) | 5.4±2.0 |
| Global Limitation Index (0–54) | 14.25±11.8 |
| Treatment | |
| NSAID (n=1,639) | 1,272 (77.6%) |
| Synthetic DMARD (n=1,597) | 652 (40.8%) |
| Biologic DMARD (n=1,636) | 709 (43.3%) |
| Mental health | |
| Depression diagnosis (n=2,034) | 610 (30.0%) |
| Anxiety diagnosis (n=2,038) | 674 (33.1%) |
| GHQ-12 (0–12) | 4.8±4.0 |
| Risk of mental disorders (GHQ-12 ≥3) | 1,314 (60.7%) |
Results are based on 2,166 respondents unless otherwise stated and are expressed as mean±SD or n (%).
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; DMARD, disease-modifying antirheumatic drug; GHQ-12, 12-item General Health Questionnaire; NSAID, nonsteroidal anti-inflammatory drug.